Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
According to Maia’s survey, most of the sales channels for prescription drugs are still hospitals and clinics. The sales through clinics accounted for 50.36% in 2019, and the sales through hospitals accounted for 35.05%.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Prescription Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Prescription Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Prescription Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teva Pharmaceutical
Pfizer, Inc
Takeda Pharmaceutical
Johnson & Johnson
AbbVie, Inc
Boehringer Ingelheim GmbH
Celgene Corporation
Amgen, Inc
Bristol-Myers Squibb Company
Bayer AG
F Hoffmann-La Roche AG
Novartis International AG
AstraZeneca PLC
Merck & Co, Inc
GlaxoSmithKline PLC
Sanofi
Allergan PLC
Gilead Sciences, Inc
Eli Lilly and Company
Novo Nordisk A/S
By Type:
Brand Drugs
Generic Drug
By End-User:
Online Sales
Hospital
Clinic
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Prescription Drugs Market Size and Growth Rate of Brand Drugs from 2016 to 2027
-
1.3.2 USA Prescription Drugs Market Size and Growth Rate of Generic Drug from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Prescription Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
1.4.2 USA Prescription Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 USA Prescription Drugs Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.4 USA Prescription Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Prescription Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Prescription Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Brand Drugs
-
3.4.2 Market Size and Growth Rate of Generic Drug
4 Segmentation of Prescription Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Prescription Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Prescription Drugs in Online Sales
-
4.4.2 Market Size and Growth Rate of Prescription Drugs in Hospital
-
4.4.3 Market Size and Growth Rate of Prescription Drugs in Clinic
-
4.4.4 Market Size and Growth Rate of Prescription Drugs in Other
5 Market Analysis by Regions
-
5.1 USA Prescription Drugs Production Analysis by Regions
-
5.2 USA Prescription Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Prescription Drugs Landscape Analysis
-
6.1 West USA Prescription Drugs Landscape Analysis by Major Types
-
6.2 West USA Prescription Drugs Landscape Analysis by Major End-Users
7 South USA Prescription Drugs Landscape Analysis
-
7.1 South USA Prescription Drugs Landscape Analysis by Major Types
-
7.2 South USA Prescription Drugs Landscape Analysis by Major End-Users
8 Middle West USA Prescription Drugs Landscape Analysis
-
8.1 Middle West USA Prescription Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Prescription Drugs Landscape Analysis by Major End-Users
9 Northeast USA Prescription Drugs Landscape Analysis
-
9.1 Northeast USA Prescription Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Prescription Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Teva Pharmaceutical
-
10.1.1 Teva Pharmaceutical Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Pfizer, Inc
-
10.2.1 Pfizer, Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Takeda Pharmaceutical
-
10.3.1 Takeda Pharmaceutical Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Johnson & Johnson
-
10.4.1 Johnson & Johnson Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AbbVie, Inc
-
10.5.1 AbbVie, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Boehringer Ingelheim GmbH
-
10.6.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Celgene Corporation
-
10.7.1 Celgene Corporation Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Amgen, Inc
-
10.8.1 Amgen, Inc Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Bristol-Myers Squibb Company
-
10.9.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Bayer AG
-
10.10.1 Bayer AG Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 F Hoffmann-La Roche AG
-
10.11.1 F Hoffmann-La Roche AG Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Novartis International AG
-
10.12.1 Novartis International AG Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AstraZeneca PLC
-
10.13.1 AstraZeneca PLC Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Merck & Co, Inc
-
10.14.1 Merck & Co, Inc Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 GlaxoSmithKline PLC
-
10.15.1 GlaxoSmithKline PLC Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Sanofi
-
10.16.1 Sanofi Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Allergan PLC
-
10.17.1 Allergan PLC Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Gilead Sciences, Inc
-
10.18.1 Gilead Sciences, Inc Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
-
10.19 Eli Lilly and Company
-
10.19.1 Eli Lilly and Company Company Profile and Recent Development
-
10.19.2 Market Performance
-
10.19.3 Product and Service Introduction
-
10.20 Novo Nordisk A/S
-
10.20.1 Novo Nordisk A/S Company Profile and Recent Development
-
10.20.2 Market Performance
-
10.20.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Prescription Drugs Market Size and Growth Rate of Brand Drugs from 2016 to 2027
-
Figure USA Prescription Drugs Market Size and Growth Rate of Generic Drug from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Prescription Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
Figure USA Prescription Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Prescription Drugs Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Prescription Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Prescription Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Prescription Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Prescription Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Prescription Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Brand Drugs
-
Figure Market Size and Growth Rate of Generic Drug
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Prescription Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Prescription Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Online Sales
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table USA Prescription Drugs Production by Regions
-
Table USA Prescription Drugs Production Share by Regions
-
Figure USA Prescription Drugs Production Share by Regions in 2016
-
Figure USA Prescription Drugs Production Share by Regions in 2021
-
Figure USA Prescription Drugs Production Share by Regions in 2027
-
Table USA Prescription Drugs Consumption by Regions
-
Table USA Prescription Drugs Consumption Share by Regions
-
Figure USA Prescription Drugs Consumption Share by Regions in 2016
-
Figure USA Prescription Drugs Consumption Share by Regions in 2021
-
Figure USA Prescription Drugs Consumption Share by Regions in 2027
-
Table West USA Prescription Drugs Consumption by Types from 2016 to 2027
-
Table West USA Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Prescription Drugs Consumption Share by Types in 2016
-
Figure West USA Prescription Drugs Consumption Share by Types in 2021
-
Figure West USA Prescription Drugs Consumption Share by Types in 2027
-
Table West USA Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Prescription Drugs Consumption Share by End-Users in 2016
-
Figure West USA Prescription Drugs Consumption Share by End-Users in 2021
-
Figure West USA Prescription Drugs Consumption Share by End-Users in 2027
-
Table South USA Prescription Drugs Consumption by Types from 2016 to 2027
-
Table South USA Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Prescription Drugs Consumption Share by Types in 2016
-
Figure South USA Prescription Drugs Consumption Share by Types in 2021
-
Figure South USA Prescription Drugs Consumption Share by Types in 2027
-
Table South USA Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Prescription Drugs Consumption Share by End-Users in 2016
-
Figure South USA Prescription Drugs Consumption Share by End-Users in 2021
-
Figure South USA Prescription Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Prescription Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Prescription Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Prescription Drugs Consumption Share by Types in 2027
-
Table Middle West USA Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Prescription Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Prescription Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Prescription Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Prescription Drugs Consumption Share by Types in 2027
-
Table Northeast USA Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Prescription Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
Table Company Profile and Development Status of Pfizer, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc
-
Figure Sales and Growth Rate Analysis of Pfizer, Inc
-
Figure Revenue and Market Share Analysis of Pfizer, Inc
-
Table Product and Service Introduction of Pfizer, Inc
-
Table Company Profile and Development Status of Takeda Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
-
Table Product and Service Introduction of Takeda Pharmaceutical
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of AbbVie, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie, Inc
-
Figure Sales and Growth Rate Analysis of AbbVie, Inc
-
Figure Revenue and Market Share Analysis of AbbVie, Inc
-
Table Product and Service Introduction of AbbVie, Inc
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-
Table Company Profile and Development Status of Amgen, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc
-
Figure Sales and Growth Rate Analysis of Amgen, Inc
-
Figure Revenue and Market Share Analysis of Amgen, Inc
-
Table Product and Service Introduction of Amgen, Inc
-
Table Company Profile and Development Status of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of F Hoffmann-La Roche AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG
-
Table Product and Service Introduction of F Hoffmann-La Roche AG
-
Table Company Profile and Development Status of Novartis International AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG
-
Figure Sales and Growth Rate Analysis of Novartis International AG
-
Figure Revenue and Market Share Analysis of Novartis International AG
-
Table Product and Service Introduction of Novartis International AG
-
Table Company Profile and Development Status of AstraZeneca PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC
-
Figure Sales and Growth Rate Analysis of AstraZeneca PLC
-
Figure Revenue and Market Share Analysis of AstraZeneca PLC
-
Table Product and Service Introduction of AstraZeneca PLC
-
Table Company Profile and Development Status of Merck & Co, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
-
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
-
Figure Revenue and Market Share Analysis of Merck & Co, Inc
-
Table Product and Service Introduction of Merck & Co, Inc
-
Table Company Profile and Development Status of GlaxoSmithKline PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline PLC
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline PLC
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline PLC
-
Table Product and Service Introduction of GlaxoSmithKline PLC
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Allergan PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan PLC
-
Figure Sales and Growth Rate Analysis of Allergan PLC
-
Figure Revenue and Market Share Analysis of Allergan PLC
-
Table Product and Service Introduction of Allergan PLC
-
Table Company Profile and Development Status of Gilead Sciences, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences, Inc
-
Figure Sales and Growth Rate Analysis of Gilead Sciences, Inc
-
Figure Revenue and Market Share Analysis of Gilead Sciences, Inc
-
Table Product and Service Introduction of Gilead Sciences, Inc
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Novo Nordisk A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S
-
Figure Sales and Growth Rate Analysis of Novo Nordisk A/S
-
Figure Revenue and Market Share Analysis of Novo Nordisk A/S
-
Table Product and Service Introduction of Novo Nordisk A/S
-
